Literature DB >> 23184690

Cooperative, nanoparticle-enabled thermal therapy of breast cancer.

Haifa Shen1, Jian You, Guodong Zhang, Arturas Ziemys, Qingpo Li, Litao Bai, Xiaoyong Deng, Donald R Erm, Xuewu Liu, Chun Li, Mauro Ferrari.   

Abstract

Hollow gold nanoshells are more efficient in heat generation triggered by near infrared laser when they are loaded into porous silicon particles, which results in effective cancer-cell killing in vitro and in vivo. Collective electromagnetic coupling of nanoconfined hollow gold nanoshells leads to dramatic enhancement of thermal ablation.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh：

Year:  2011        PMID： 23184690      PMCID： PMC3842222          DOI： 10.1002/adhm.201100005

Source DB:  PubMed          Journal:  Adv Healthc Mater        ISSN： 2192-2640            Impact factor:   9.933


  41 in total

1.  Width of cluster plasmon resonances: Bulk dielectric functions and chemical interface damping.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1993-12-15

2.  Local detection of electromagnetic energy transport below the diffraction limit in metal nanoparticle plasmon waveguides.

Authors:  Stefan A Maier; Pieter G Kik; Harry A Atwater; Sheffer Meltzer; Elad Harel; Bruce E Koel; Ari A G Requicha
Journal:  Nat Mater       Date:  2003-04       Impact factor: 43.841

Review 3.  A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies.

Authors:  Laura C Kennedy; Lissett R Bickford; Nastassja A Lewinski; Andrew J Coughlin; Ying Hu; Emily S Day; Jennifer L West; Rebekah A Drezek
Journal:  Small       Date:  2010-12-14       Impact factor: 13.281

4.  Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer.

Authors:  William J Gradishar; Sergei Tjulandin; Neville Davidson; Heather Shaw; Neil Desai; Paul Bhar; Michael Hawkins; Joyce O'Shaughnessy
Journal:  J Clin Oncol       Date:  2005-09-19       Impact factor: 44.544

5.  Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer.

Authors:  Nuhad K Ibrahim; Brian Samuels; Ray Page; Dinesh Doval; Kirtikumar M Patel; S C Rao; Madhavan Krishnan Nair; Paul Bhar; Neil Desai; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

6.  Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors.

Authors:  Marissa N Balak; Yixuan Gong; Gregory J Riely; Romel Somwar; Allan R Li; Maureen F Zakowski; Anne Chiang; Guangli Yang; Ouathek Ouerfelli; Mark G Kris; Marc Ladanyi; Vincent A Miller; William Pao
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

7.  A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin.

Authors:  A Rahman; J Treat; J K Roh; L A Potkul; W G Alvord; D Forst; P V Woolley
Journal:  J Clin Oncol       Date:  1990-06       Impact factor: 44.544

8.  Near-infrared narrow-band imaging of gold/silica nanoshells in tumors.

Authors:  Priyaveena Puvanakrishnan; Jaesook Park; Parmeswaran Diagaradjane; Jon A Schwartz; Chris L Coleman; Kelly L Gill-Sharp; Kristina L Sang; J Donald Payne; Sunil Krishnan; James W Tunnell
Journal:  J Biomed Opt       Date:  2009 Mar-Apr       Impact factor: 3.170

9.  Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model.

Authors:  Jon A Schwartz; Anil M Shetty; Roger E Price; R Jason Stafford; James C Wang; Rajesh K Uthamanthil; Kevin Pham; Roger J McNichols; Chris L Coleman; J Donald Payne
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

10.  Experimental and theoretical studies of light-to-heat conversion and collective heating effects in metal nanoparticle solutions.

Authors:  Hugh H Richardson; Michael T Carlson; Peter J Tandler; Pedro Hernandez; Alexander O Govorov
Journal:  Nano Lett       Date:  2009-03       Impact factor: 11.189
View more
  27 in total

1.  A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells.

Authors:  Bronwyn Scott; Jianliang Shen; Sara Nizzero; Kathryn Boom; Stefano Persano; Yu Mi; Xuewu Liu; Yuliang Zhao; Elvin Blanco; Haifa Shen; Mauro Ferrari; Joy Wolfram
Journal:  Pharmacol Res       Date:  2016-07-06       Impact factor: 7.658

Review 2.  Strategies to target tumors using nanodelivery systems based on biodegradable polymers, aspects of intellectual property, and market.

Authors:  Michele F Oliveira; Pedro P G Guimarães; Alinne D M Gomes; Diego Suárez; Rubén D Sinisterra
Journal:  J Chem Biol       Date:  2012-11-30

3.  Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer.

Authors:  Chaofeng Mu; Xiaoyan Wu; Xinyu Zhou; Joy Wolfram; Jianliang Shen; Dechen Zhang; Junhua Mai; Xiaojun Xia; Ashley M Holder; Mauro Ferrari; Xuewu Liu; Haifa Shen
Journal:  Clin Cancer Res       Date:  2018-06-19       Impact factor: 12.531

4.  Evaluation of cell function upon nanovector internalization.

Authors:  Jonathan O Martinez; Alessandro Parodi; Xuewu Liu; Mikhail G Kolonin; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-11-20       Impact factor: 13.281

5.  Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery.

Authors:  Haifa Shen; Cristian Rodriguez-Aguayo; Rong Xu; Vianey Gonzalez-Villasana; Junhua Mai; Yi Huang; Guodong Zhang; Xiaojing Guo; Litao Bai; Guoting Qin; Xiaoyong Deng; Qingpo Li; Donald R Erm; Burcu Aslan; Xuewu Liu; Jason Sakamoto; Arturo Chavez-Reyes; Hee-Dong Han; Anil K Sood; Mauro Ferrari; Gabriel Lopez-Berestein
Journal:  Clin Cancer Res       Date:  2013-02-05       Impact factor: 12.531

6.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

7.  Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

Authors:  Junhua Mai; Yi Huang; Chaofeng Mu; Guodong Zhang; Rong Xu; Xiaojing Guo; Xiaojun Xia; David E Volk; Ganesh L Lokesh; Varatharasa Thiviyanathan; David G Gorenstein; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

8.  Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors.

Authors:  Jonathan O Martinez; Christian Boada; Iman K Yazdi; Michael Evangelopoulos; Brandon S Brown; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Small       Date:  2012-12-16       Impact factor: 13.281

9.  Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions.

Authors:  Alessandro Parodi; Nicoletta Quattrocchi; Anne L van de Ven; Ciro Chiappini; Michael Evangelopoulos; Jonathan O Martinez; Brandon S Brown; Sm Z Khaled; Iman K Yazdi; Maria Vittoria Enzo; Lucas Isenhart; Mauro Ferrari; Ennio Tasciotti
Journal:  Nat Nanotechnol       Date:  2012-12-16       Impact factor: 39.213

10.  An injectable nanoparticle generator enhances delivery of cancer therapeutics.

Authors:  Rong Xu; Guodong Zhang; Junhua Mai; Xiaoyong Deng; Victor Segura-Ibarra; Suhong Wu; Jianliang Shen; Haoran Liu; Zhenhua Hu; Lingxiao Chen; Yi Huang; Eugene Koay; Yu Huang; Jun Liu; Joe E Ensor; Elvin Blanco; Xuewu Liu; Mauro Ferrari; Haifa Shen
Journal:  Nat Biotechnol       Date:  2016-03-14       Impact factor: 54.908
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.